|
![]() |
RamiprilThis page contains recent news articles, when available, and an overview of Ramipril but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Ramipril (when available) Ramipril is an angiotensin-converting enzyme (ACE) inhibitor similar to benazepril, fosinopril, and quinapril. An inactive prodrug, ramipril is converted to ramiprilat in the liver and is used to treat hypertension and heart failure, to reduce proteinuria and renal disease in patients with nephropathies, and to prevent stroke, myocardial infarction, and cardiac death in high-risk patients. Indicated for diuretics and digitalis in congestive heart failure as adjunctive therapy; prophylaxis in post MI. Mechanism Of Action: Ramiprilat, the active metabolite, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blood pressure and an increase in plasma renin. Ramiprilat may also act on kininase II, an enzyme identical to ACE that degrades the vasodilator bradykinin. News Articles on Ramipril Studio Italiano Sugli Effetti CARDIOvascolari del Controllo della ... - Aug 13, 2009 ...ramipril 5 or 10 mg/day, telmisartan 80 mg/day, amlodipine (5 or 10 mg/day), bisoprolol (5 mg/day), or transdermal clonidine (2.5 or 5 mg/day). Cardiosource King Pharmaceuticals Reports Second Quarter 2009 Financial Results - Aug 6, 2009 The decrease in revenues was primarily due to the market entry of generic substitutes for ALTACE(R) (ramipril) beginning in December 2007. FOXBusiness Modifiche AIC in GU: Humira, Otrivin, Ramipril FG, Copaxone - Aug 13, 2009 Gazzetta Ufficiale: Modificate le autorizzazioni all'immissione in commercio di Humira, Otrivin, Ramipril FG, Copaxone. Aggiunta la seguente indicazione Pillole.org Triatec efficace nella prevenzione delle recidive di fibrillazione ... - Aug 19, 2009 Dopo un periodo osservazionale di 3 anni, le recidive di fibrillazione atriale sono state osservate in 3 pazienti, trattati con Ramipril e in 10 pazienti XagenaSalute 丹å?‚ 郄è?‰è?‰ - Aug 24, 2009 ...ä»–ç ”ç©¶æ‰€å¾—çš„ç»“è®ºæ˜¯ï¼Œå’Œæ·±å?—è¥¿åŒ»å–œçˆ±çš„è¡€ç®¡ç´§å¼ ç´ è½¬æ?¢é…¶æŠ‘制剂“雷米普利â€?(Ramipril)相比,丹å?‚在缩å°?心梗é?¢ç§¯æ–¹é?¢å’Œé›·ç±³æ™®åˆ©å?Œæ ·æœ‰æ•ˆï¼Œè€Œä¸”在å‡?少氧化应激 中国农业网 Telmisartan en prévention CV - Aug 11, 2009 ...le telmisartan satisfaisait le critère de non-infériorité par rapport au ramipril sur le critère primaire associant décès cardiovasculaires, IDM, theheart.org/fr 09:49 GAZZETTA UFFICIALE: SOMMARIO (2) - Aug 20, 2009 149) Modificazione dell'autorizzazione all'immissione in commercio, secondo procedura di mutuo riconoscimento, del medicinale "Ramipril Idroclorotiazide ANSA Valle d'Aosta Angiotensin inhibition in the prevention of atrial fibrillation - Jul 1, 2009 Lastly, the recent ONTARGET study, which evaluated telmisartan (Micardis, Boehringer Ingelheim), ramipril or the combination in high-risk patients, Cardiology Today Rasilez - Japanese Ministry of Health approves Rasilez®, a first ... - Jul 7, 2009 Blood Pressure Reduction Following A Simulated Missed Dose Of Aliskiren, Irbesartan, or Ramipril: A Comparative Ambulatory Blood Pressure Monitoring Study. Ad-Hoc-News (Pressemitteilung) A Downside to Angiotensin Blockade? - Jun 18, 2009 The study showed that a combination of telmisartan and ramipril reduces proteinuria to a greater extent than monotherapy, but overall, the combination Renal and Urology News Appliance, gun, prescription drugs among stolen items - Jun 24, 2009 During the break-in, various prescription drugs were stolen, including Xanax, Lortab, Lexapro, Ramipril, Diovan HTC, Plavix and Metoprolol Tartarte. Prattville Progress Ask Dr Mel: Head injuries and polypills - Jul 3, 2009 ...thiazide (a diuretic or water pill), and ramipril (an ACE inhibitor). Only aspirin and simvastatin can be bought without a prescription in the UK. goodtoknow Watson Pharma to buy Arrow group for $1.75B - Jun 17, 2009 Arrow also sells a generic version of the blood pressure drug Altace, or ramipril, said Watson CEO Paul Bisaro. It is also one of the companies challenging The Associated Press Ramipril frena la evolución de la insuficiencia renal en niños - Jun 26, 2009 La utilización de ramipril, un inhibidor de la enzima convertidora de la angiotensina, consigue una evolución más lenta de la insuficiencia renal en niños Diario Médico (Suscripción) Ramipril преди лÑ?гане подобрÑ?ва нощниÑ? контрол на кръвното ... - Jul 1, 2009 Приемът на ACE-инхибитора ramipril преди лÑ?гане повишава антихипертензивниÑ? ефект на препарата по време на Ñ?ън, докладват иÑ?панÑ?ки лекари в юлÑ?киÑ? брой на DoctorBG.com FARMACI: AUMENTANO CONSUMI, 924 DOSI AL GIORNO OGNI 1000 ITALIANI (2) - Jul 9, 2009 La sostanza piu' prescritta e' risultata essere, nel 2008, il ramipril (contro l'ipertensione). Altre sostanze rilevanti per consumo sono l'acido Agenzia di Stampa Asca Farmaci, l'Italia è un paese per vecchi: il boom dei cardiovascolari - Jul 9, 2009 La sostanza più prescritta è risultata essere nel 2008 il Ramipril (contro l'ipertensione). Di che tipo di medicinale si tratta? Il Salvagente Modifiche AIC in GU: Cepim, Altersol, Triatec, Ramipril Sanofi ... - Jun 25, 2009 Gazzetta Ufficiale: Modificate le autorizzazioni all'immissione in commercio di Cepim, Altersol, Triatec, Ramipril Sanofi-Aventis, Efexor, Uniclar. Pillole.org æ—¥, 혈압약 'ë?¼ì‹¤ë ˆì¦ˆ' 시íŒ?승ì?¸ - Jul 9, 2009 ...다른 í•ê³ í˜ˆì••ì œì?¸ 'hydrochlorothiazide(diuretic)' 'ramipril(ACE inhibitor)' 'amlodipine(calcium channel blocker)' 등과 ë³‘ìš©í• ë•Œ 효과가 극대화 ë?˜ë©° ë¯¸êµ 헬스코리아뉴스 GAZZETTA UFFICIALE: SOMMARIO (3) - Jul 9, 2009 Modificazione dell'autorizzazione all'immissione in commercio del medicinale per uso umano "Ramipril e Idroclorotiazide Sanofi-Aventis". ANSA Valle d'Aosta ノãƒ?ルティスã€?ç›´æŽ¥çš„ãƒ¬ãƒ‹ãƒ³é˜»å®³å‰¤ï¼ˆï¼¤ï¼²ï¼©ï¼‰ã€Œãƒ©ã‚¸ãƒ¬ã‚¹éŒ ï¼‘ï¼•ï¼?ï½?g ... - Jul 7, 2009 ...Aliskiren ï¼ï½?nï½?therï½?ï½?ï½™ Lï½?wers Blï½?ï½?d Pressure ï¼ï½?ï½’ï½… Effectively thï½?n ï¼²ï½?ï½?iï½?ril 日本経済新聞 (プレスリリース) Ocho de cada diez pacientes hipertensos con riesgo cardiovascular ... - Jul 3, 2009 Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine 2008; 358(15):1547-59. 15 . Nissen SE, et al. acceso.com (Comunicado de prensa) Neue Runde im «Pille-Wechsle-Dich» - Jun 30, 2009 Der Hersteller Winthrop übernimmt für den gesamten AOK-Markt mit 24 Millionen Versicherten die Versorgung mit dem Blutdrucksenker Ramipril, einem ähnlichen PR-Inside.com (Pressemitteilung) Las enfermedades cardiovasculares requieren un abordaje integral y ... - Jun 25, 2009 ...seiscientos de ellos españoles, han demostrado que telmisartan es tan eficaz como el tratamiento de referencia actual ramipril 3 . acceso.com (Comunicado de prensa) VérnyomáscsökkentÅ‘k: az ACE-gátlók működése és hatásai - Jun 22, 2009 Magyarországon a következÅ‘ ACE-gátló hatóanyagok vannak forgalomban: kaptopril, enalapril, lizinopril, perindopril, ramipril, quinapril, benazepril, WEBBeteg Telmisartan in pazienti intolleranti ad ACE inibitori - Jun 18, 2009 La popolazione in studio era leggermente differente rispetto a quella dello studio HOPE, in cui il ramipril ha ridotto del 22% l'end point combinato morte Pillole.org GAZZETTA UFFICIALE: SOMMARIO (2) - Jun 19, 2009 Modificazione dell'autorizzazione all'immissione in commercio del medicinale per uso umano "Ramipril Sanofi-Aventis". Modificazione dell'autorizzazione ANSA Valle d'Aosta Brand Names/Synonyms: Ramipril is also known by the following brand names and/or synonymsAcovil; Altace; Carasel; Cardace; Delix; HOE 498; Hytren; Lostapres; Pramace; Quark; Ramace; Ramipril; Ramipril [Usan:Ban:Inn]; Ramiprilum [Latin]; Triatec; Tritace; Unipril; Vesdil Drug Category: Ramipril is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA05 Dosage Forms: CAPSULE Absorption: The extent of absorption is at least 50-60% and is not significantly influenced by the presence of food in the GI tract, although the rate of absorption is reduced. Interactions: Interactions for Ramipril: With nonsteroidal anti-inflammatory agents: Rarely, concomitant treatment with ACE inhibitors and nonsteroidal anti-inflammatory agents have been associated with worsening of renal failure and an increase in serum potassium. With Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with ramipril. The possibility of hypotensive effects with ramipril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with ramipril. If this is not possible, the starting dose should be reduced. With Potassium Supplements and Potassium-sparing Diuretics: Ramipril can attenuate potassium loss caused by thiazide diuretics. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. Therefore, if concomitant use of such agents is indicated, they should be given with caution, and the patient's serum potassium should be monitored frequently. With Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. These drugs should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended. If a diuretic is also used, the risk of lithium toxicity may be increased. Other: Neither ramipril nor its metabolites have been found to interact with food, digoxin, antacid, furosemide, cimetidine, indomethacin, and simvastatin. The combination of ramipril and propranolol showed no adverse effects on dynamic parameters (blood pressure and heart rate). The co-administration of ramipril and warfarin did not adversely affect the anticoagulant effects of the latter drug. Additionally, co-administration of ramipril with phenprocoumon did not affect minimum phenprocoumon levels or interfere with the subjects' state of anti-coagulation. Chemical IUPAC Name: 4-[2-(1-ethoxycarbonyl-3-phenyl-propyl)aminopropanoyl]-4-azabicyclo[3.3.0]octane-3-carboxylicacid : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |